Printer Friendly

BLOCK DRUG COMPANY, INC. REPORTS PRELIMINARY NINE MONTHS AND THIRD QUARTER SALES AND EARNINGS

 JERSEY CITY, N.J., Jan. 26 /PRNewswire/ -- Block Drug Company, Inc. (NASDAQ-NMS: BLOCA) today reported sales for the third quarter ended Dec. 31, 1992 increased by 13.6 percent to $157,311,000 from $138,502,000 for the same period in 1991. Net earnings after taxes rose to $14,890,000, equal to $.79 per share, compared with $13,723,000 or $.72 per share earned a year ago.
 Sales for the first nine months were $470,005,000, an increase of 12.4 percent over the same period last year. Net earnings for the nine months were $46,674,000 or earnings per share of $2.46 compared to $2.24 for the same period in 1991.
 A dividend in the amount of $.25 per share has been declared payable April 1, 1993 to class A common stockholders of record March 1, 1993.
 BLOCK DRUG COMPANY, INC.
 Preliminary Consolidated Statements of Income (A)
 Periods ended Nine months Quarter
 Dec. 31 1992 1991 1992 1991
 Net sales $470,005,000 $418,043,000 $157,311,000 $138,502,000
 Income before
 provision
 for taxes 58,343,000 54,055,000 18,613,000 17,200,000
 Net income 46,674,000 42,433,000 14,890,000 13,723,000(C)
 Average number
 of shares
 outstanding 18,934,076(B) 18,920,204(B) 18,937,887 18,923,558(B)
 Net income
 per share 2.46(B) 2.24(B) .79 .72(B)
 (A) Unaudited
 (B) Average number of shares outstanding and net income per share have been restated for the 3 percent stock dividend declared in October 1992.
 (C) The prior year quarter's results include a one-time, after-tax charge of $2,647,000, representing the cost of correcting certain manufacturing difficulties which occurred at a plant operated by one of the company's international subsidiaries. Also included are after-tax gains of $1,940,000 on the sale of marketable securities.
 -0- 1/26/93
 /CONTACT: Melvin Kopp, senior vice president and controller of Block Drug Company, Inc., 201-434-3000/
 (BLOC)


CO: Block Drug Company, Inc. ST: New Jersey IN: MTC SU: ERN

SM-OS -- NY088 -- 9174 01/26/93 14:51 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 26, 1993
Words:362
Previous Article:PRAXAIR DECLARES QUARTERLY DIVIDEND
Next Article:PNC'S CITIZENS FIDELITY BANK NAMES NEW CEO
Topics:


Related Articles
BLOCK DRUG REPORTS YEAR-END AND FOURTH QUARTER SALES AND EARNINGS
BLOCK DRUG COMPANY REPORTS PRELIMINARY FIRST QUARTER SALES AND EARNINGS
MARION MERRELL DOW REPORTS 16 PERCENT GAIN IN THIRD-QUARTER EARNINGS PER SHARE
BLOCK DRUG COMPANY REPORTS PRELIMINARY FIRST QUARTER SALES AND EARNINGS
SPI PHARMACEUTICALS THIRD QUARTER NET INCOME AND SALES UP 46 PERCENT and 32 PERCENT; NINE MONTHS EARNINGS PER SHARE UP 66 PERCENT
BLOCK DRUG COMPANY, INC. REPORTS PRELIMINARY SIX MONTHS AND SECOND QUARTER SALES AND EARNINGS
BLOCK DRUG COMPANY, INC. REPORTS PRELIMINARY SIX MONTHS AND SECOND QUARTER SALES AND EARNINGS
BIOGEN REPORTS $25 MILLION CHARGE TO EARNINGS IN Q3
ICN PHARMACEUTICALS REPORTS RECORD SALES, NET INCOME AND EARNINGS PER SHARE IN THIRD QUARTER
Block Drug Company Reports Third Quarter & Nine Month Sales; Earnings Acquisitions Announced.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters